When the primary objective of the study was the overall survival of tumor-bearing animals, the use of plasma samples collected from lysozyme-treated mice in conjunction with the surgical removal of the primary tumor increased the number of cured animals from 10% to 40% [32]. The gene discussed is LYZ; the disease is neoplasm.